China
· Delayed Price · Currency is CNY Boai NKY Medical Holdings Statistics
Total Valuation
SHE:300109 has a market cap or net worth of CNY 8.41 billion. The enterprise value is 7.99 billion.
| Market Cap | 8.41B |
| Enterprise Value | 7.99B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jun 7, 2024 |
Share Statistics
SHE:300109 has 484.70 million shares outstanding. The number of shares has decreased by -0.13% in one year.
| Current Share Class | 484.70M |
| Shares Outstanding | 484.70M |
| Shares Change (YoY) | -0.13% |
| Shares Change (QoQ) | -6.54% |
| Owned by Insiders (%) | 19.99% |
| Owned by Institutions (%) | 6.68% |
| Float | 383.42M |
Valuation Ratios
The trailing PE ratio is 27.12.
| PE Ratio | 27.12 |
| Forward PE | n/a |
| PS Ratio | 5.47 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 48.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.33, with an EV/FCF ratio of -83.62.
| EV / Earnings | 25.87 |
| EV / Sales | 5.20 |
| EV / EBITDA | 17.33 |
| EV / EBIT | 22.18 |
| EV / FCF | -83.62 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.13.
| Current Ratio | 2.57 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 1.05 |
| Debt / FCF | -5.04 |
| Interest Coverage | 45.48 |
Financial Efficiency
Return on equity (ROE) is 8.29% and return on invested capital (ROIC) is 5.72%.
| Return on Equity (ROE) | 8.29% |
| Return on Assets (ROA) | 5.23% |
| Return on Invested Capital (ROIC) | 5.72% |
| Return on Capital Employed (ROCE) | 9.52% |
| Revenue Per Employee | 1.32M |
| Profits Per Employee | 265,445 |
| Employee Count | 1,163 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 2.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.83% in the last 52 weeks. The beta is -0.08, so SHE:300109's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +49.83% |
| 50-Day Moving Average | 16.03 |
| 200-Day Moving Average | 14.40 |
| Relative Strength Index (RSI) | 61.09 |
| Average Volume (20 Days) | 11,140,585 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300109 had revenue of CNY 1.54 billion and earned 308.71 million in profits. Earnings per share was 0.64.
| Revenue | 1.54B |
| Gross Profit | 682.09M |
| Operating Income | 360.16M |
| Pretax Income | 350.35M |
| Net Income | 308.71M |
| EBITDA | 459.05M |
| EBIT | 360.16M |
| Earnings Per Share (EPS) | 0.64 |
Balance Sheet
The company has 872.91 million in cash and 481.81 million in debt, giving a net cash position of 391.10 million or 0.81 per share.
| Cash & Cash Equivalents | 872.91M |
| Total Debt | 481.81M |
| Net Cash | 391.10M |
| Net Cash Per Share | 0.81 |
| Equity (Book Value) | 3.69B |
| Book Value Per Share | 7.67 |
| Working Capital | 1.12B |
Cash Flow
In the last 12 months, operating cash flow was 174.22 million and capital expenditures -269.75 million, giving a free cash flow of -95.53 million.
| Operating Cash Flow | 174.22M |
| Capital Expenditures | -269.75M |
| Free Cash Flow | -95.53M |
| FCF Per Share | -0.20 |
Margins
Gross margin is 44.39%, with operating and profit margins of 23.44% and 20.09%.
| Gross Margin | 44.39% |
| Operating Margin | 23.44% |
| Pretax Margin | 22.80% |
| Profit Margin | 20.09% |
| EBITDA Margin | 29.88% |
| EBIT Margin | 23.44% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.44%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.44% |
| Dividend Growth (YoY) | 200.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 106.73% |
| Buyback Yield | 0.13% |
| Shareholder Yield | 1.54% |
| Earnings Yield | 3.67% |
| FCF Yield | -1.14% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 7, 2024. It was a forward split with a ratio of 1.5.
| Last Split Date | Jun 7, 2024 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
SHE:300109 has an Altman Z-Score of 6.04.
| Altman Z-Score | 6.04 |
| Piotroski F-Score | n/a |